APA (7th ed.) Citation

Bilal, H., Khan, M. N., Khan, S., Fang, W., Chang, W., Yin, B., . . . Zeng, Y. (2024). Risk of candidiasis associated with interleukin-17 inhibitors: Implications and management. Mycology: An International Journal on Fungal Biology, 15(1), 30. https://doi.org/10.1080/21501203.2023.2265664

Chicago Style (17th ed.) Citation

Bilal, Hazrat, et al. "Risk of Candidiasis Associated with Interleukin-17 Inhibitors: Implications and Management." Mycology: An International Journal on Fungal Biology 15, no. 1 (2024): 30. https://doi.org/10.1080/21501203.2023.2265664.

MLA (9th ed.) Citation

Bilal, Hazrat, et al. "Risk of Candidiasis Associated with Interleukin-17 Inhibitors: Implications and Management." Mycology: An International Journal on Fungal Biology, vol. 15, no. 1, 2024, p. 30, https://doi.org/10.1080/21501203.2023.2265664.